Cardiovascular Diseases (CVD): Clinical Trials

50 trials for Cardiovascular Diseases (CVD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 recruiting, 14 not yet recruiting, 6 completed, 4 active not recruiting. 23 Not applicable, 5 Phase 2, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable23Recruiting 9, Not yet recruiting 7, Completed 4, Active not recruiting 2, Unknown 1
Phase 25Not yet recruiting 2, Recruiting 2, Completed 1
Phase 32Completed 1, Not yet recruiting 1
Early Phase 11Not yet recruiting 1
Phase 11Recruiting 1
Phase 41Not yet recruiting 1

Follow Cardiovascular Diseases (CVD): new trials by email Literature Review of Cardiovascular Diseases (CVD) trials Research Report on Cardiovascular Diseases (CVD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of the "Aktivplan" Digital Intervention for Supporting Regular Heart-Healthy Physical Activity Following Phase II Cardiac Rehabilitation
aktivplan - Cardiovascular Diseases (CVD)
Not applicableNot yet recruitingSalzburg Research Forschungsgesellschaft mbH682027-03-012026-10-16
Reducing Arterial Inflammation Using Eplerenone and Statins in HIV
Eplerenone, Placebo - HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD)
Phase 2 / Phase 3Not yet recruitingMassachusetts General Hospital1242027-03-012026-10-23
wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65
Arm 1: wCAR-CARE - Precision Prevention (Arm A), Guideline-directed standard of care - Cardiovascular Diseases (CVD), Coronary Artery Disease
Not applicableNot yet recruitingWomen's Heart Austria8002027-01-012026-09-30
EValuation of prognostIc and Cost reDuction by tElemonitoring iN CIEDs Usual carE: an Updated Analysis Using 2019-2023 Data
No RM exposure, RM exposure, Conventional RM - Cardiovascular Diseases (CVD), Cardiac Implantable Electronic Device (CIED)
Active not recruitingImplicity1000002026-10-072026-10-19
Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP)
Automated Office Blood Pressure (AOBP) Standardized Measurement Protocol - Hypertension, Cardiovascular Diseases (CVD)
Not applicableNot yet recruitingMenzies Institute for Medical Research60002026-10-012026-09-16
Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System
Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System, Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE TTVR System - Severe Tricuspid Valve Regurgitation, Tricuspid Valve Regurgitation
Not applicableNot yet recruitingLaplace Interventional, Inc7002026-09-012026-07-22
Evaluate the Value of Modified Shock Index in Predicting the Incidence of Cardiovascular Events After Non-cardiac Surgery in Cardiac Patients
Cardiovascular Diseases (CVD), Postoperative
Not yet recruitingFujian Medical University Union Hospital15002026-08-012026-07-30
Prebiotic Inulin for Late-Reproductive Individuals
Inulin, Maltodextrin (Placebo) - Obesity & Overweight, Perimenopausal Women
Not applicableRecruitingGeorge Washington University272026-08-012026-08-11
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne System, Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE System - Tricuspid Valve Regurgitation, Tricuspid Valve Disease
Not applicableRecruitingVDyne, Inc.7302026-07-282026-08-17
Palmitic Acid and Human Microvascular Function
Quercetin (dietary supplement), Placebo - Microvascular Dysfunction, Microvasculature
Phase 2Not yet recruitingMedical College of Wisconsin402026-07-012026-04-29
Multi-organ Imaging of Microvascular and Metabolic Function
18F-FDG, Positron Emission Tomography (PET) - Healthy Subjects (HS), Cardiovascular Diseases (CVD)
Early Phase 1Not yet recruitingMassachusetts General Hospital602026-07-012026-05-22
Randomized Cross-Over Comparison of Medium Cut-Off and High-Flux Hemodialysis Membranes
Medium Cut-Off Hemodialysis Membrane, High-Flux Hemodialysis Membrane - End Stage Kidney Disease (ESKD), Hemodialysis
Not applicableActive not recruitingGazi University302026-07-012026-09-09
Colchicine to Reduce Coronary Artery Inflammation in People With HIV
Colchicine 0.5 mg, Placebo - HIV Infection, Cardiovascular Diseases (CVD)
Phase 2RecruitingInstituto de Investigación Hospital Universitario La Paz902026-06-012026-07-15
European Study of the BrioVAD Heart Pump for Advanced Heart Failure
LVAD implantation - Refractory Heart Failure, Cardiovascular Diseases (CVD)
Not applicableRecruitingBrioHealth BV602026-06-012026-06-22
The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings.
5g of prebiotic fibre and 300mg of magnesium (WellBiome), 5g of maltodextrin - Cardiovascular Diseases (CVD), Cardiovascular Surgery
Not applicableRecruitingHull University Teaching Hospitals NHS Trust802026-04-092026-06-23
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
Cardiovascular Diseases (CVD), Chronic Kidney Disease
RecruitingFirst Affiliated Hospital of Fujian Medical University80002026-03-012026-04-23
Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study
Standard Medical Therapy, Revascularization Procedures, Lifestyle Modification - Cardiovascular Diseases (CVD), Cerebro Vascular Disease
RecruitingSamsung Medical Center8000002026-02-022026-04-28
Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects
Saccharin, Sucralose, Erythritol - Prediabetic State, Metabolic Syndrome
Not applicableNot yet recruitingCharite University, Berlin, Germany802026-01-052026-01-29
Data Donation Model for Inclusive Cardiovascular Prevention Using the TRAIN Health Platform
Digital Lifestyle Feedback Module (optional) - Cardiovascular Diseases (CVD)
Not yet recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)4502026-01-012025-11-20
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention
RecruitingUniversity College Dublin1002025-12-092026-02-10

Showing 20 of 50. Sign in to see all of them.

Narrower conditions

Cardiovascular Diseases (50)  ·  Obesity (5)  ·  Renal Insufficiency, Chronic (5)  ·  Coronary Artery Disease (4)  ·  Hypertension (4)  ·  Metabolic Syndrome (4)  ·  Overweight (4)  ·  Atherosclerosis (3)  ·  Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 2 (3)  ·  Prediabetic State (3)  ·  Heart Failure (2)  ·  Heart Valve Diseases (2)  ·  Inflammation (2)  ·  Insulin Resistance (2)

Broader conditions

Vascular Diseases (14)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Pathologic Processes (11)  ·  Nutritional and Metabolic Diseases (10)  ·  Urogenital Diseases (10)  ·  Chronic Disease (9)  ·  Disease Attributes (9)  ·  Female Urogenital Diseases (8)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Glucose Metabolism Disorders (8)  ·  Heart Diseases (8)  ·  Kidney Diseases (8)  ·  Male Urogenital Diseases (8)  ·  Urologic Diseases (8)  ·  Metabolic Diseases (7)

Interventions

maltodextrin (2)  ·  Amlodipine, Valsartan Drug Combination (1)  ·  Atorvastatin (1)  ·  Colchicine (1)  ·  Dietary Supplements (1)  ·  Duloxetine Hydrochloride (1)  ·  Eplerenone (1)  ·  Erythritol (1)  ·  Escitalopram (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Fluoxetine (1)  ·  Fluvoxamine (1)  ·  Hematinics (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Inulin (1)

Sponsors

Guangdong Provincial People's Hospital (2)  ·  Massachusetts General Hospital (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Ankara University (1)  ·  Asfendiyarov Kazakh National Medical University (1)  ·  Beni-Suef University (1)  ·  BrioHealth BV (1)  ·  Center for Molecular Fingerprinting Research Nonprofit LLC (1)  ·  Chang Gung Memorial Hospital (1)  ·  Charite University, Berlin, Germany (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  China-Japan Friendship Hospital (1)  ·  First Affiliated Hospital of Fujian Medical University (1)  ·  First Hospital of China Medical University (1)  ·  Fondation Ildys (1)

Countries

China (9)  ·  United States (6)  ·  Austria (2)  ·  Egypt (2)  ·  France (2)  ·  Kazakhstan (2)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  Greece (1)

Top investigators

Aris Citra Wisuda, PhD (1)  ·  Brandon Jones, MD (1)  ·  Charanjit Rihal, MD (1)  ·  Dajun Chai (1)  ·  Eng Sing Lee (1)  ·  Ferenc Krausz, Prof, PhD (1)  ·  Georgios Hillas (1)  ·  Jeffrey Alten (1)  ·  Kashish Goel, MD (1)  ·  Liping Yu, Doctor (1)  ·  Ludmila Cardozo, PhD (1)  ·  Nicholas S Peters, MD (1)

Results publications

PMID 30183376, PMID 31089513, PMID 31636122, PMID 31707507, PMID 33251828, PMID 35231009, PMID 35762156, PMID 35983178, PMID 38153260, PMID 38170622, PMID 40551890, PMID 40830908, PMID 41668846, PMID 42512238

NIH funding

2019 (1), K23HL170836 (1)